| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.3M | +50.1% |
| Cost of Revenue | $14.2M | +93.0% |
| R&D Expense | $2.9M | +101.9% |
| SG&A Expense | $9.4M | -24.9% |
| Operating Income | -$3.8M | +46.1% |
| Pre-tax Income | -$2.6M | +28.6% |
| Income Tax | $228K | +242.4% |
| Net Income | -$2.9M | +23.8% |
| EPS (Basic) | -$0.09 | +25.0% |
| EPS (Diluted) | -$0.09 | +25.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | +181.1% |
| Short-term Investments | $18.6M | -38.8% |
| Accounts Receivable | $5.6M | +42.1% |
| Current Assets | $42.6M | -4.3% |
| Total Assets | $44.1M | -6.4% |
| Current Liabilities | $14.4M | -13.6% |
| Total Liabilities | $14.4M | -16.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.9M | +920.6% |
| Investing Cash Flow | $12.9M | -25.1% |
| Financing Cash Flow | -$7.5M | +60.5% |
| $29.8M |
| -0.9% |